Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3850015 | American Journal of Kidney Diseases | 2010 | 5 Pages |
Abstract
Nonionic low-osmolar contrast agents are considered safe for intravenous or intra-arterial administration and are used widely in the general population, as well as in patients on hemodialysis therapy. There are data limited to case reports for contrast-induced hearing loss; however, the ototoxicity induced by contrast agents in patients with chronic kidney disease has never been described. We report a case of permanent sensorineural deafness after abdominal aortic angiography with iopamidol in a woman with end-stage renal disease on hemodialysis therapy and review the literature relating to contrast use with the development of hearing impairment.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Mohammed R. MD, Leah MD, Sofia MD,